My PCR
Create Account
Logo PCR

19 May 2026

Stents, scaffolds and DCBOther coronary interventions

Rethinking stentless PCI strategy - Improving outcomes with Bioadaptor

Sponsored by Elixir Medical

Anchorperson: S. Verheye
Spokesperson: N. Werner
SHOW MORE

Summary

This EuroPCR 2026 session explores contemporary PCI strategies through the concept of stentless intervention using the Bioadaptor device in complex coronary disease.

It highlights the bioadaptive design features of Bioadaptor and reviews the supporting clinical evidence, with a focus on how this technology may influence procedural outcomes.

The discussion also addresses patient and lesion selection, clarifying which clinical scenarios may benefit most from this approach.

Through a series of case presentations—including multivessel disease, bifurcation lesions, and calcified complex lesions—the session provides practical insights into the application of bioadaptive angioplasty in everyday interventional practice.

Learning Objectives

  • To participate in the discussion on the modern PCI treatment strategies and how clinical decisions are made 
  • To learn the unique design characteristics of Bioadaptor and clinical evidence and how those could improve PCI clinical outcomes 
  • To better understand the patients and lesions that can be safely and effectively treated with Bioadaptor 
Related Content
Sirolimus-Eluting Balloon vs. Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary... FFRangio, are we ready for everyday practice? Refactory angina and coronary sinus reducer, from established applications to future outlooks
Recommended for you
AICT-AsiaPCR 2026: what’s new this year? iCABG: iFR vs. angiography guided CABG TARGET-FIRST